Chronic forms of urticaria are common. often adversely impacting on quality
of life. No formal studies have assessed the extent and nature of disabili
ty in different types of urticaria. The Dermatology Life Quality Index (DLQ
I) is a simple and validated 10-item questionnaire designed to measure and
compare disability in different skin conditions. In this study, we aimed to
assess the disability in different urticarial groups using the DLQI, allow
ing comparison with previously published DLQI scores in common skin disease
s. The DLQI was administered to 170 consecutive patients attending a specia
list urticaria clinic over a 4-month period. Consistent with previous studi
es using the DLQI, mean scores were not influenced by gender or age. Patien
ts with chronic idiopathic urticaria without a concurrent physical urticari
a (n = 47) suffered moderate quality of life impairment (mean +/- SD DLQI 2
5 +/- 24%). In comparison, patients with chronic idiopathic urticaria with
concurrent delayed pressure urticaria (DPU) (n = 26) suffered significantly
higher quality of life impairment (mean +/- SD DLQI 43 +/- 23%, 95% confid
ence interval for difference 7-29%). Disability in this group was greatest
in the dimensions of work/study, symptoms/feelings and leisure. Subjects wi
th another form of physical urticaria, cholinergic urticaria, also endured
high levels of disability (n=9, mean +/- SD DLQI 50 +/- 34%). From our urti
caria study group, we have shown that subjects with DPU and cholinergic urt
icaria endure the most quality of life impairment. The mean DLQI scores dem
onstrated in these groups are comparable with those previously seen in seve
re atopic dermatitis out-patients (60%) and higher than those seen in out-p
atients with psoriasis (29.7%), acne (24.3%) and vitiligo (16.1%).